You are here

SPN-812

FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day

Endpoints

Tue, 11/10/20 - 10:40 am

Parkinson's Disease

Supernus Pharmaceuticals seeks FDA approval for ADHD drug

Bizjournals

Tue, 11/12/19 - 07:52 pm

Supernus Pharmaceuticals

Tardy marketing application filing, trial failure troubles Supernus investors

Endpoints

Wed, 11/6/19 - 10:23 am

clinical trials

Supernus struggles to gain attention

EP Vantage

Fri, 03/29/19 - 10:23 am

clinical trials

As with children studies, Supernus ADHD drug shows fast onset of action in adolescents

Endpoints

Thu, 12/20/18 - 10:10 am

Supernus Pharmaceuticals

clinical trials

Supernus says ADHD drug trounces rivals, but shares slide

Pharmaforum

Fri, 12/7/18 - 10:48 am

clinical trials

Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline in ADHD

BioMedReports

Sat, 01/7/12 - 02:34 pm

Supernus Pharmaceuticals